Organon & Co. OGN

Latest FY: 2025 Healthcare Drug Manufacturers - General
Market Price $13.63
Market Cap $3.58B
P/E Ratio 18.94
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-2.9% YoY
$6.22B
3-Yr CAGR: 0.2%
Net Income ↓-78.4% YoY
$187.00M
Net Margin: 3.0%
Free Cash Flow ↓-29.6% YoY
$538.00M
FCF Yield: 15.03%
EPS (Diluted) ↓-78.4% YoY
$0.72
Basic: $0.72
Return on Equity Efficiency
24.9%
ROA: 1.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (OGN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $9,777.0M $5,084.0M $2,153.0M $3,687.0M $3,586.0M
FY 2019 $7,777.0M -20.5% $5,503.0M $3,218.0M +49.5% $12.69 $2,767.0M $2,658.0M -25.9%
FY 2020 $6,532.0M -16.0% $4,413.0M $2,160.0M -32.9% $8.52 -32.9% $2,187.0M $1,909.0M -28.2%
FY 2021 $6,304.0M -3.5% $3,922.0M $1,351.0M -37.5% $5.31 -37.7% $0.57 1.87% $2,458.0M $2,266.0M +18.7%
FY 2022 $6,174.0M -2.1% $3,880.0M $917.0M -32.1% $3.59 -32.4% $1.12 4.01% $917.0M $721.0M -68.2%
FY 2023 $6,263.0M +1.4% $3,748.0M $1,023.0M +11.6% $3.99 +11.1% $1.12 7.77% $1,023.0M $772.0M +7.1%
FY 2024 $6,403.0M +2.2% $3,715.0M $864.0M -15.5% $3.33 -16.5% $1.12 7.51% $939.0M $764.0M -1.0%
FY 2025 $6,216.0M -2.9% $3,313.0M $187.0M -78.4% $0.72 -78.4% $0.34 4.74% $700.0M $538.0M -29.6%
$

Valuation

Market Price $13.63
Market Cap $3.58B
Enterprise Value $11.65B
P/E Ratio 18.94
P/B Ratio 4.76
FCF Yield 15.03%
Dividend Yield 2.49%
Shares Outstanding 262,600,900
%

Profitability & Margins

Gross Margin 53.30%
Operating Margin 1.91%
Net Margin 3.01%
Return on Equity (ROE) 24.87%
Return on Assets (ROA) 1.45%
Asset Turnover 0.48x
Revenue 3-Yr CAGR 0.23%
🛡️

Financial Health & Liquidity

Current Ratio 1.82
Cash Ratio 0.24
Debt / Equity 11.495
Debt / Assets 0.672
Cash & Equivalents $574.00M
Total Debt $8.64B
Book Value / Share $2.86
💧

Cash Flow Efficiency

Operating Cash Flow $700.00M
Capital Expenditures (CapEx) $162.00M
Free Cash Flow $538.00M
OCF / Revenue 11.26%
FCF / Revenue 8.66%
FCF 3-Yr CAGR -9.30%
🏷️

Per Share Metrics

EPS (Diluted) $0.72
EPS (Basic) $0.72
Dividends / Share $0.34
Book Value / Share $2.86
EPS YoY Growth -78.38%
🏛️

Balance Sheet (FY 2025)

Total Assets $12.87B
Total Liabilities $12.12B
Stockholders' Equity $752.00M
Current Assets $4.35B
Current Liabilities $2.39B